Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

Details for Australian Patent Application No. 2004218354 (hide)

Owner Halozyme, Inc.

Inventors Frost, Gregory I.; Bookbinder, Louis H.; Kundu, Anirban

Agent Freehills

Pub. Number AU-B-2004218354

PCT Pub. Number WO2004/078140

Priority 60/452,360 05.03.03 US

Filing date 5 March 2004

Wipo publication date 16 September 2004

Acceptance publication date 1 October 2009

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/00 (2006.01)

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/47 (2006.01) Medicinal preparations containing peptides

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 1/20 (2006.01) Micro-organisms, e.g. protozoa - Bacteria

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

C12N 9/26 (2006.01) Enzymes, e.g. ligases (6.) - acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase

C12N 11/08 (2006.01) Carrier-bound or immobilised enzymes

C12N 11/10 (2006.01) Carrier-bound or immobilised enzymes

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/078140 Priority application(s): WO2004/078140

1 October 2009 Application Accepted

  Published as AU-B-2004218354

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218358-Compositions and methods for preventing and treating endotoxin-related diseases and conditions

2004218353-Antimicrobial solution and process